What does CUSIP 89357L105 represent in this 13F holders report?

CUSIP 89357L105 is the security identifier for RNAZ - TRANSCODE THERAPEUTICS INC - COM used to aggregate holder disclosures.

How many institutions held RNAZ - TRANSCODE THERAPEUTICS INC - COM in Q1 2023?

11 institutional investors reported RNAZ - TRANSCODE THERAPEUTICS INC - COM for Q1 2023. Use the holders table for investor-level position and value details.

TRANSCODE THERAPEUTICS INC - COM (RNAZ)

CUSIP: 89357L105

Q1 2023 13F Holders as of 31 Mar 2023

Security type / class: Equity / COM
Total 13F shares: 262,198
Total 13F value: $88,633
Share change: -35,952
SEC-reported price per share: $0.34
Number of holders: 11
Value change: -$45,999
Number of buys: 4
Number of sells: 11

Security key

89357L105

Report period

Q1 2023

Institutions

Top holders

RNAZ full security history Ownership snapshot Full 13F holder table Transcode Therapeutics, Inc. SEC filings Transcode Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of RNAZ - TRANSCODE THERAPEUTICS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Anna Moore

Disclosed value leader

Anna Moore

Comparable rows

0/15

Latest evidence

31 Dec 2022

3/4/5 13F Highest disclosed value: $791,920 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Anna Moore has the largest disclosed position value at $791.9K.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Anna Moore's linked filing trail.

Disclosed position value Top 5

Anna Moore $791.9K

GEODE CAPITAL MANAGEMENT, LLC $51K

Cahill Wealth Management, LLC $22.9K

HRT FINANCIAL LP $17K

SHEETS SMITH WEALTH MANAGEMENT $16.8K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Anna Moore	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$791,920 1,552,785 shares	—	08 Jul 2021
Zdravka Medarova	3/4/5 Chief Technology Officer, 10%+ Owner 3/4/5	— denominator unverified	— 60,000 shares	—	12 Dec 2022
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$51,000 76,549 shares	—	31 Dec 2022
Cahill Wealth Management, LLC	13F Company 13F	— denominator unverified	$22,946 47,060 shares	—	31 Dec 2022
HRT FINANCIAL LP	13F Company 13F	— denominator unverified	$17,000 25,995 shares	—	31 Dec 2022
SHEETS SMITH WEALTH MANAGEMENT	13F Company 13F	— denominator unverified	$16,825 25,000 shares	—	31 Dec 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

262,198

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q1 2023 Shares	Share Diff	Share Chg %	Q1 2023 value	Q1 2023 value	Value change	Value Chg %